Giang Nguyen
Podiatrist · New Orleans, LANPI 1366751109
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,845 of the $2,439 with a category attached, or 75.6%. 11 manufacturers reported payments, led by Stryker at 54.7% of the total. Reporting peaked in 2019 at $877 and has fallen 78.0% since, to $193 in 2025. That places this record below the midpoint for podiatrist clinicians in LA, where the typical reported total is $2,398.
Across 72 payments — averaging $33.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$1K
- Paratek Pharmaceuticals, Inc.$530
- Organogenesis Inc.$178
- Smith+Nephew$146
- Mimedx Group, Inc.$112
- Arthrosurface Incorporated$32
- plus $107 from 5 others
What the payments were for
- Travel & lodging$59424%
- Food & beverage$1,84576%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 18 | $1,335 |
| Paratek Pharmaceuticals, Inc. | 35 | $530 |
| Organogenesis Inc. | 5 | $178 |
| Smith+Nephew | 6 | $146 |
| Mimedx Group, Inc. | 2 | $112 |
| Arthrosurface Incorporated | 1 | $32 |
| Baxter Healthcare | 1 | $27 |
| ALON Medical Technology | 1 | $26 |
| Sanara Medtech Inc. | 1 | $21 |
| Acera Surgical, Inc. | 1 | $19 |
| KCI USA, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ANCHORAGE$655
- ACTISHIELD CF$159
- NUZYRA$109
How this compares
$2,439 in reported general payments places this provider in the 50th percentile of 68 podiatrist providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JubliaEfinaconazole | 12 | $17,743 |
| Ciclopirox | 80 | $2,295 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 54 | $1,162 |
| Diclofenac Sodium | 34 | $880 |
| Neomycin-Polymyxin-HcNeomycin/Polymyxin B/Hydrocort | 14 | $808 |
| Ammonium Lactate | 62 | $720 |
| Ketoconazole | 20 | $521 |
| Terbinafine Hcl | 23 | $198 |
| Gabapentin | 25 | $191 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 22 | $166 |
| Doxycycline Hyclate | 15 | $94 |
| Mupirocin | 13 | $90 |
| Meloxicam | 23 | $32 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in New Orleans
- Nneka MekaNew Orleans$9K
- Dayna BoltonNew Orleans$9K
- Edward LangNew Orleans$7K
- Sandreka JonesNew Orleans$6K
- Erin BujolNew Orleans$3K
- Nhu HoangNew Orleans$3K
- Joshua NeesonNew Orleans$1K
- Maxime SavardKenner$74K
- David TranMonroe$24K
- Tyler TewilliagerHouma$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.